EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterization of 53 Multiplexed Targeted Proteomics Assays for Verification Studies in Cancer Cell Lines

Constance A Sobsey iD, Gerald Batist, Christoph H Borchers iD

Journal of Proteome Research · 2025

DOI: 10.1021/acs.jproteome.4c00576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2025. Verfasst von Constance A Sobsey und 2 weiteren Autor:innen. Beteiligte Einrichtung: Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montreal, Quebec H3T 1E2, C…. Hauptthemen laut MEDLINE: Proteomics, Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds de Recherche du Qu?bec - Sant?, Genome British Columbia, Jewish General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsBiomarkers, TumorNeoplasmsHumansCell Line, TumorPeptidesMass SpectrometryReproducibility of Results

Stichwörter der Autor:innen

Clinical Proteomic Tumor Analysis Consortium (CPTAC)biomarker verificationfit-for-purpose assay validationinternal standardsmass spectrometrymultiple reaction monitoring (MRM)multiplexed quantitationtargeted proteomicstranslational control

Substanzen

Biomarkers, TumorPeptides

Autor:innen und Institutionen

  • Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montreal, Quebec H3T 1E2, Canada.
  • Division of Experimental Medicine, McGill University, Montreal, Quebec H3T 1E2, Canada.
  • Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec H4A 3T2, Canada.
  • McGill Centre for Translational Research in Cancer, Lady Davis Institute for Medical Research, Montreal, Quebec H3T 1E2, Canada.
  • Gerald Bronfman Department of Oncology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec H3T 1E2, Canada.
  • Department of Pathology, McGill University, Montreal, Quebec H3A 2B4, Canada.

ORCID-Profile: Constance A Sobsey, Christoph H Borchers

Förderung

  • Fonds de Recherche du Qu?bec - Sant?
  • Genome British Columbia
  • Jewish General Hospital
  • Genome Canada
  • Quebec Cancer Consortium

Zitieren

APA

Sobsey, C. A., Batist, G., & Borchers, C. H. (2025). Characterization of 53 Multiplexed Targeted Proteomics Assays for Verification Studies in Cancer Cell Lines. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.4c00576

Vancouver

Sobsey CA, Batist G, Borchers CH. Characterization of 53 Multiplexed Targeted Proteomics Assays for Verification Studies in Cancer Cell Lines. Journal of Proteome Research. 2025. doi:10.1021/acs.jproteome.4c00576

BibTeX
@article{Sobsey2025,
  author = {Sobsey, Constance A and Batist, Gerald and Borchers, Christoph H},
  title = {Characterization of 53 Multiplexed Targeted Proteomics Assays for Verification Studies in Cancer Cell Lines},
  journal = {Journal of Proteome Research},
  year = {2025},
  doi = {10.1021/acs.jproteome.4c00576}
}
Kostenlos starten →